C18-GG-BP100

General Information


DRACP ID  DRACP03836

Peptide Name   C18-GG-BP100

Sequence  GGKKLFKKILKYL

Sequence Length  13

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  C18

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C76H130N18O15

Absent amino acids  ACDEHMNPQRSTVW

Common amino acids  K

Mass  175021

Pl  11.02

Basic residues  5

Acidic residues  0

Hydrophobic residues  5

Net charge  5

Boman Index  -335

Hydrophobicity  -22.31

Aliphatic Index  120

Half Life 
  Mammalian: 4.4 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  1490

Absorbance 280nm  124.17

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 28831625

Title  Synthesis and biological evaluation of novel aliphatic acid-conjugated antimicrobial peptides as potential agents with anti-tumor, multidrug resistance-reversing activity and enhanced stability

Doi Not available

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13473

DRACP is developed by Dr.Zheng's team.